Even in the boardrooms of Pfizer, they had to have expected President Trump’s Twitter outburst on Monday. If anything, the Pfizer executives set themselves up to be a target.
Let’s look back to the end of May, when Trump promised that some big drug makers would take “voluntary, massive” price cuts in two weeks.
Well, it’s been close to six weeks and, so far, most large brand-name drug makers have not heeded his call, although few companies raised prices by any meaningful amount, either. This is a time of year, after all, when the pharmaceutical industry traditionally increases prices.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
